The goal of this research study is to evaluate the effectiveness, tolerability and safety of rivastigmine capsules in males and females between the ages of 50 and 85 years old with probable vascular dementia.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
708
Change in cognition from baseline at week 24
Global clinical impression of change from baseline at week 24
Change in activities of daily living from baseline at week 24
Change in behavioral symptoms from baseline at week 24
Change in clinical staging from baseline at week 24
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Unnamed facility
Irvine, California, United States
Unnamed facility
San Francisco, California, United States
Unnamed facility
Boynton Beach, Florida, United States
Unnamed facility
Miami Beach, Florida, United States
Unnamed facility
Port Charlotte, Florida, United States
Unnamed facility
Indianapolis, Indiana, United States
Unnamed facility
Des Moines, Iowa, United States
Unnamed facility
St Louis, Missouri, United States
Unnamed facility
Albuquerque, New Mexico, United States
Unnamed facility
New York, New York, United States
...and 53 more locations